Factors | Patients (N) | Recurrence | P value | |
---|---|---|---|---|
Positive | Negative | |||
Gender | 0.369# | |||
Male | 32 | 5 | 27 | |
Female | 10 | 3 | 7 | |
Age (years) | 0.709# | |||
< 65 | 23 | 5 | 18 | |
≥65 | 19 | 3 | 16 | |
Follow-up time, median (range, month) | – | 27.5(3-33) | 28.5(1-91) | 0.1768 |
Postoperative hospital stay, median (range, day) | – | 12.5(9-21) | 12(8-55) | 0.9009 |
Surgical methods | 0.824# | |||
B I | 5 | 1 | 4 | |
DG + R-Y | 7 | 2 | 5 | |
TG + R-Y | 30 | 5 | 25 | |
BMI, median (range, Kg/m2) | – | 21.6(19.5-27.8) | 23.3(17.3-30.5) | 0.6709 |
Neoadjuvant chemotherapy | 0.479# | |||
Yes | 3 | 1 | 2 | |
None | 39 | 7 | 32 | |
Hypertension | 1.000# | |||
Yes | 8 | 1 | 7 | |
None | 34 | 7 | 27 | |
Diabetes | 1.000# | |||
Yes | 3 | 0 | 3 | |
None | 39 | 8 | 31 | |
Number of primary tumors | 0.158# | |||
Two | 38 | 6 | 32 | |
Three | 3 | 1 | 2 | |
Four | 1 | 1 | 0 | |
Tumor size | 1.000# | |||
< 2 cm | 2 | 0 | 2 | |
≥2 cm | 40 | 8 | 32 | |
Histological type (Adenocarcinoma)a | 0.635# | |||
Well-differentiated | 8 | 2 | 6 | |
Poorly-differentiated | 34 | 6 | 28 | |
Consistency of histology | 1.000# | |||
Positive | 24 | 5 | 19 | |
Negative | 18 | 3 | 15 | |
Invasive depthb | 0.308# | |||
T1 | 15 | 1 | 14 | |
T2 | 6 | 1 | 5 | |
T3-T4 | 21 | 6 | 15 | |
Consistency of invasive depth | 0.697# | |||
Positive | 21 | 5 | 16 | |
Negative | 21 | 3 | 18 | |
Lymph node metastasis | 0.045*# | |||
Yes | 17 | 6 | 11 | |
None | 25 | 2 | 23 | |
Ulcer | 1.000# | |||
Positive | 38 | 7 | 31 | |
Negative | 4 | 1 | 3 | |
Lymphovascular cancer plug | 0.162# | |||
Positive | 8 | 3 | 5 | |
Negative | 34 | 5 | 29 | |
Nerve invasion | 0.075# | |||
Positive | 10 | 4 | 6 | |
Negative | 32 | 4 | 28 | |
Preoperative CEA, median (range, ng/ml) | – | 1.96 (0.476–22.59) | 2.36 (0.2–23.5) | 0.8142 |
Preoperative CA19-9, median (range, U/ml) | – | 7.3 (1.28–32.85) | 10.31 (1.63–32.82) | 0.3112 |
Preoperative AFP, median (range, ng/ml) | – | 3.37 (1.18–8.25) | 2.72 (0.947–5.92) | 0.0791 |
Preoperative CA153, median (range, U/ml) | – | 10.22 (4.92–16.59) | 8.51 (3.44–20.82) | 0.9523 |
Preoperative CA125, median (range, U/ml) | – | 10.2 (7.09–17.2) | 11.145 (3.28–27.61) | 0.8395 |
Preoperative CA724, median (range, U/ml) | – | 1.81 (0.699–4.06) | 1.61 (0.2–141.1) | 0.6102 |
Operation time, median (range, minute) | – | 167.5 (110–240) | 166.5 (102–330) | 0.8218 |
Distant metastasis | 0.19# | |||
Positive | 1 | 1 | 0 | |
Negative | 41 | 7 | 34 | |
Postoperative complication | 0.479# | |||
Yes | 3 | 1 | 2 | |
None | 39 | 7 | 32 | |
Total | 42 | 8 | 34 |